{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:48:52Z","timestamp":1791895732812,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T00:00:00Z","timestamp":1585958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T00:00:00Z","timestamp":1585958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK114006"],"award-info":[{"award-number":["DK114006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00018-020-03511-0","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T07:02:28Z","timestamp":1585983748000},"page":"3831-3840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Melanocortin 5 receptor signaling pathway in health and disease"],"prefix":"10.1007","volume":"77","author":[{"given":"Yahong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6302-2800","authenticated-orcid":false,"given":"Rujun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,4]]},"reference":[{"key":"3511_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1999.tb08662.x","volume":"885","author":"ME Hadley","year":"1999","unstructured":"Hadley ME, Haskell-Luevano C (1999) The proopiomelanocortin system. Ann N Y Acad Sci 885:1\u201321","journal-title":"Ann N Y Acad Sci"},{"key":"3511_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/phrs.2000.0725","volume":"42","author":"JE Wikberg","year":"2000","unstructured":"Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A (2000) New aspects on the melanocortins and their receptors. Pharmacol Res 42:393\u2013420","journal-title":"Pharmacol Res"},{"key":"3511_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ijo.0800786","volume":"23","author":"RA Norman","year":"1999","unstructured":"Norman RA, Permana P, Tanizawa Y, Ravussin E (1999) Absence of genetic variation in some obesity candidate genes (GLP1R, ASIP, MC4R, MC5R) among Pima indians. Int J Obes Relat Metab Disord 23:163\u2013165","journal-title":"Int J Obes Relat Metab Disord"},{"key":"3511_CR4","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/endo.139.5.6008","volume":"139","author":"M van der Kraan","year":"1998","unstructured":"van der Kraan M, Adan RA, Entwistle ML, Gispen WH, Burbach JP, Tatro JB (1998) Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139:2348\u20132355","journal-title":"Endocrinology"},{"key":"3511_CR5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1006\/bbrc.1993.2125","volume":"195","author":"V Chhajlani","year":"1993","unstructured":"Chhajlani V, Muceniece R, Wikberg JE (1993) Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 195:866\u2013873","journal-title":"Biochem Biophys Res Commun"},{"key":"3511_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0149-7634(82)90042-2","volume":"6","author":"PC Datta","year":"1982","unstructured":"Datta PC, King MG (1982) Alpha-melanocyte-stimulating hormone and behavior. Neurosci Biobehav Rev 6:297\u2013310","journal-title":"Neurosci Biobehav Rev"},{"key":"3511_CR7","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1152\/ajpendo.00434.2002","volume":"284","author":"I Gantz","year":"2003","unstructured":"Gantz I, Fong TM (2003) The melanocortin system. Am J Physiol Endocrinol Metab 284:E468\u2013E474","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3511_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","volume":"56","author":"A Catania","year":"2004","unstructured":"Catania A, Gatti S, Colombo G, Lipton JM (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56:1\u201329","journal-title":"Pharmacol Rev"},{"key":"3511_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2003.tb03175.x","volume":"994","author":"L Zhang","year":"2003","unstructured":"Zhang L, Anthonavage M, Huang Q, Li WH, Eisinger M (2003) Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci 994:154\u2013161","journal-title":"Ann N Y Acad Sci"},{"key":"3511_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2230.2006.02128.x","volume":"31","author":"GW Millington","year":"2006","unstructured":"Millington GW (2006) Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 31:407\u2013412","journal-title":"Clin Exp Dermatol"},{"key":"3511_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/PL00000868","volume":"58","author":"ZA Abdel-Malek","year":"2001","unstructured":"Abdel-Malek ZA (2001) Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58:434\u2013441","journal-title":"Cell Mol Life Sci"},{"key":"3511_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0165-6147(02)02103-X","volume":"23","author":"SJ Getting","year":"2002","unstructured":"Getting SJ (2002) Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends Pharmacol Sci 23:447\u2013449","journal-title":"Trends Pharmacol Sci"},{"key":"3511_CR13","doi-asserted-by":"crossref","first-page":"32085","DOI":"10.1016\/S0021-9258(18)31604-1","volume":"269","author":"JM Camadro","year":"1994","unstructured":"Camadro JM, Thome F, Brouillet N, Labbe P (1994) Purification and properties of protoporphyrinogen oxidase from the yeast Saccharomyces cerevisiae. Mitochondrial location and evidence for a precursor form of the protein. J Biol Chem 269:32085\u201332091","journal-title":"J Biol Chem"},{"key":"3511_CR14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1389450033490858","volume":"4","author":"J Voisey","year":"2003","unstructured":"Voisey J, Carroll L, van Daal A (2003) Melanocortins and their receptors and antagonists. Curr Drug Targets 4:586\u2013597","journal-title":"Curr Drug Targets"},{"key":"3511_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-3083.2005.01565.x","volume":"61","author":"GN Andersen","year":"2005","unstructured":"Andersen GN, Hagglund M, Nagaeva O, Frangsmyr L, Petrovska R, Mincheva-Nilsson L, Wikberg JE (2005) Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol 61:279\u2013284","journal-title":"Scand J Immunol"},{"key":"3511_CR16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1006\/bbrc.1994.1580","volume":"200","author":"I Gantz","year":"1994","unstructured":"Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T (1994) Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200:1214\u20131220","journal-title":"Biochem Biophys Res Commun"},{"key":"3511_CR17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1006\/bbrc.1994.1550","volume":"200","author":"N Griffon","year":"1994","unstructured":"Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz JC, Sokoloff P (1994) Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem Biophys Res Commun 200:1007\u20131014","journal-title":"Biochem Biophys Res Commun"},{"key":"3511_CR18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1523-1747.2000.00094.x","volume":"115","author":"D Thiboutot","year":"2000","unstructured":"Thiboutot D, Sivarajah A, Gilliland K, Cong Z, Clawson G (2000) The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J Invest Dermatol 115:614\u2013619","journal-title":"J Invest Dermatol"},{"key":"3511_CR19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(00)80467-5","volume":"91","author":"W Chen","year":"1997","unstructured":"Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, Cone RD (1997) Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91:789\u2013798","journal-title":"Cell"},{"key":"3511_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/chemse\/bjh011","volume":"29","author":"C Morgan","year":"2004","unstructured":"Morgan C, Thomas RE, Ma W, Novotny MV, Cone RD (2004) Melanocortin-5 receptor deficiency reduces a pheromonal signal for aggression in male mice. Chem Senses 29:111\u2013115","journal-title":"Chem Senses"},{"key":"3511_CR21","first-page":"53","volume":"52","author":"AW Taylor","year":"2006","unstructured":"Taylor AW, Kitaichi N, Biros D (2006) Melanocortin 5 receptor and ocular immunity. Cell Mol Biol 52:53\u201359","journal-title":"Cell Mol Biol"},{"key":"3511_CR22","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1074\/jbc.M603454200","volume":"282","author":"JJ An","year":"2007","unstructured":"An JJ et al (2007) Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J Biol Chem 282:2862\u20132870","journal-title":"J Biol Chem"},{"key":"3511_CR23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molmet.2016.07.009","volume":"5","author":"PJ Enriori","year":"2016","unstructured":"Enriori PJ et al (2016) \u03b1-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors. Mol Metab 5:807\u2013822","journal-title":"Mol Metab"},{"key":"3511_CR24","first-page":"1267","volume":"1831","author":"AR Rodrigues","year":"2013","unstructured":"Rodrigues AR, Almeida H, Gouveia AM (2013) Alpha-MSH signalling via melanocortin 5 receptor promotes lipolysis and impairs re-esterification in adipocytes. Biochem Biophys Acta 1831:1267\u20131275","journal-title":"Biochem Biophys Acta"},{"key":"3511_CR25","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/bi00181a015","volume":"33","author":"O Labb\u00e9","year":"1994","unstructured":"Labb\u00e9 O, Desarnaud F, Eggerickx D, Vassart G, Parmentier M (1994) Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33:4543\u20134549","journal-title":"Biochemistry"},{"key":"3511_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000133895","volume":"68","author":"BP Chowdhary","year":"1995","unstructured":"Chowdhary BP, Gustavsson I, Wikberg JE, Chhajlani V (1995) Localization of the human melanocortin-5 receptor gene (MC5R) to chromosome band 18p11.2 by fluorescence in situ hybridization. Cytogenet Cell Genet 68:79\u201381","journal-title":"Cytogenet Cell Genet"},{"key":"3511_CR27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0888-7543(02)00037-X","volume":"81","author":"DW Logan","year":"2003","unstructured":"Logan DW, Bryson-Richardson RJ, Pagan KE, Taylor MS, Currie PD, Jackson IJ (2003) The structure and evolution of the melanocortin and MCH receptors in fish and mammals. Genomics 81:184\u2013191","journal-title":"Genomics"},{"key":"3511_CR28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1006\/bbrc.2002.6739","volume":"292","author":"P Grieco","year":"2002","unstructured":"Grieco P, Han G, Weinberg D, Van der Ploeg LH, Hruby VJ (2002) Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochem Biophys Res Commun 292:1075\u20131080","journal-title":"Biochem Biophys Res Commun"},{"key":"3511_CR29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygcen.2005.09.020","volume":"148","author":"A Takahashi","year":"2006","unstructured":"Takahashi A, Kawauchi H (2006) Evolution of melanocortin systems in fish. Gen Comp Endocrinol 148:85\u201394","journal-title":"Gen Comp Endocrinol"},{"key":"3511_CR30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1471-4159.2002.00934.x","volume":"82","author":"A Ringholm","year":"2002","unstructured":"Ringholm A, Fredriksson R, Poliakova N, Yan YL, Postlethwait JH, Larhammar D, Schioth HB (2002) One melanocortin 4 and two melanocortin 5 receptors from zebrafish show remarkable conservation in structure and pharmacology. J Neurochem 82:6\u201318","journal-title":"J Neurochem"},{"key":"3511_CR31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/er.2006-0034","volume":"27","author":"RD Cone","year":"2006","unstructured":"Cone RD (2006) Studies on the physiological functions of the melanocortin system. Endocr Rev 27:736\u2013749","journal-title":"Endocr Rev"},{"key":"3511_CR32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1440-1711.2001.01022.x","volume":"79","author":"A Taylor","year":"2001","unstructured":"Taylor A, Namba K (2001) In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 79:358\u2013367","journal-title":"Immunol Cell Biol"},{"key":"3511_CR33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tins.2008.04.002","volume":"31","author":"A Catania","year":"2008","unstructured":"Catania A (2008) Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends Neurosci 31:353\u2013360","journal-title":"Trends Neurosci"},{"key":"3511_CR34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/WNR.0b013e328354f5c1","volume":"23","author":"C Shukla","year":"2012","unstructured":"Shukla C, Britton SL, Koch LG, Novak CM (2012) Region-specific differences in brain melanocortin receptors in rats of the lean phenotype. NeuroReport 23:596\u2013600","journal-title":"NeuroReport"},{"key":"3511_CR35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrneph.2011.190","volume":"8","author":"R Gong","year":"2011","unstructured":"Gong R (2011) The renaissance of corticotropin therapy in proteinuric nephropathies. Nat Rev Nephrol 8:122\u2013128","journal-title":"Nat Rev Nephrol"},{"key":"3511_CR36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2012.447","volume":"83","author":"J Si","year":"2013","unstructured":"Si J, Ge Y, Zhuang S, Wang LJ, Chen S, Gong R (2013) Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms. Kidney Int 83:635\u2013646","journal-title":"Kidney Int"},{"key":"3511_CR37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13353-013-0163-z","volume":"54","author":"M Switonski","year":"2013","unstructured":"Switonski M, Mankowska M, Salamon S (2013) Family of melanocortin receptor (MCR) genes in mammals-mutations, polymorphisms and phenotypic effects. J Appl Genet 54:461\u2013472","journal-title":"J Appl Genet"},{"key":"3511_CR38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-2187-2-2","volume":"2","author":"DC New","year":"2007","unstructured":"New DC, Wong YH (2007) Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signal 2:2","journal-title":"J Mol Signal"},{"key":"3511_CR39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/exnr.1999.7064","volume":"157","author":"T Ichiyama","year":"1999","unstructured":"Ichiyama T, Zhao H, Catania A, Furukawa S, Lipton JM (1999) alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157:359\u2013365","journal-title":"Exp Neurol"},{"key":"3511_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2012.03.011","volume":"361","author":"AR Rodrigues","year":"2012","unstructured":"Rodrigues AR, Almeida H, Gouveia AM (2012) Melanocortin 5 receptor signaling and internalization: role of MAPK\/ERK pathway and beta-arrestins 1\/2. Mol Cell Endocrinol 361:69\u201379","journal-title":"Mol Cell Endocrinol"},{"key":"3511_CR41","doi-asserted-by":"crossref","first-page":"e9837","DOI":"10.1371\/journal.pone.0009837","volume":"5","author":"JS House","year":"2010","unstructured":"House JS, Zhu S, Ranjan R, Linder K, Smart RC (2010) C\/EBPalpha and C\/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin. PLoS One 5:e9837","journal-title":"PLoS One"},{"key":"3511_CR42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mce.2009.01.014","volume":"303","author":"AR Rodrigues","year":"2009","unstructured":"Rodrigues AR, Pignatelli D, Almeida H, Gouveia AM (2009) Melanocortin 5 receptor activates ERK1\/2 through a PI3K-regulated signaling mechanism. Mol Cell Endocrinol 303:74\u201381","journal-title":"Mol Cell Endocrinol"},{"key":"3511_CR43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj3310211","volume":"331","author":"JJ Buggy","year":"1998","unstructured":"Buggy JJ (1998) Binding of a-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak\/STAT pathway. Biochem J 331:211\u2013216","journal-title":"Biochem J"},{"key":"3511_CR44","doi-asserted-by":"crossref","first-page":"e0123232","DOI":"10.1371\/journal.pone.0123232","volume":"10","author":"E Simamura","year":"2015","unstructured":"Simamura E et al (2015) Melanocortins contribute to sequential differentiation and enucleation of human erythroblasts via melanocortin receptors 1, 2 and 5. PLoS One 10:e0123232\u2013e0123232","journal-title":"PLoS One"},{"key":"3511_CR45","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3389\/fphys.2018.01475","volume":"9","author":"MC Trotta","year":"2018","unstructured":"Trotta MC, Maisto R, Alessio N, Hermenean A, D'Amico M, Di Filippo C (2018) The melanocortin MC5R as a new target for treatment of high glucose-induced hypertrophy of the cardiac H9c2 cells. Front Physiol 9:1475\u20131475","journal-title":"Front Physiol"},{"key":"3511_CR46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/PL00000868","volume":"58","author":"ZA Abdel-Malek","year":"2001","unstructured":"Abdel-Malek ZA (2001) Melanocortin receptors: Their functions and regulation by physiological agonists and antagonists. Cellul Mol Life Sci 58:434\u2013441","journal-title":"Cellul Mol Life Sci"},{"key":"3511_CR47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yfrne.2010.09.001","volume":"32","author":"S Diano","year":"2011","unstructured":"Diano S (2011) New aspects of melanocortin signaling: a role for PRCP in alpha-MSH degradation. Front Neuroendocrinol 32:70\u201383","journal-title":"Front Neuroendocrinol"},{"key":"3511_CR48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.peptides.2007.02.012","volume":"28","author":"P Grieco","year":"2007","unstructured":"Grieco P, Cai M, Han G, Trivedi D, Campiglia P, Novellino E, Hruby VJ (2007) Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5. Peptides 28:1191\u20131196","journal-title":"Peptides"},{"key":"3511_CR49","doi-asserted-by":"crossref","first-page":"27589","DOI":"10.1038\/srep27589","volume":"6","author":"Y Qiao","year":"2016","unstructured":"Qiao Y et al (2016) MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy. Sci Rep 6:27589","journal-title":"Sci Rep"},{"key":"3511_CR50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ackd.2013.09.004","volume":"21","author":"R Gong","year":"2014","unstructured":"Gong R (2014) Leveraging melanocortin pathways to treat glomerular diseases. Adv Chronic Kidney Dis 21:134\u2013151","journal-title":"Adv Chronic Kidney Dis"},{"key":"3511_CR51","doi-asserted-by":"crossref","first-page":"7368389","DOI":"10.1155\/2016\/7368389","volume":"2016","author":"S Rossi","year":"2016","unstructured":"Rossi S et al (2016) Activation of melanocortin receptors MC 1 and MC 5 attenuates retinal damage in experimental diabetic retinopathy. Mediators Inflamm 2016:7368389","journal-title":"Mediators Inflamm"},{"key":"3511_CR52","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1021\/jm201226w","volume":"54","author":"NM Barkey","year":"2011","unstructured":"Barkey NM et al (2011) Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. J Med Chem 54:8078\u20138084","journal-title":"J Med Chem"},{"key":"3511_CR53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(03)01322-0","volume":"462","author":"JR Holder","year":"2003","unstructured":"Holder JR, Marques FF, Xiang Z, Bauzo RM, Haskell-Luevano C (2003) Characterization of aliphatic, cyclic, and aromatic N-terminally \u201ccapped\u201d His-d-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors. Eur J Pharmacol 462:41\u201352","journal-title":"Eur J Pharmacol"},{"key":"3511_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.06.022","volume":"111","author":"SJ Getting","year":"2006","unstructured":"Getting SJ (2006) Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111:1\u201315","journal-title":"Pharmacol Ther"},{"key":"3511_CR55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00429-005-0066-9","volume":"211","author":"M Nimura","year":"2006","unstructured":"Nimura M, Udagawa J, Hatta T, Hashimoto R, Otani H (2006) Spatial and temporal patterns of expression of melanocortin type 2 and 5 receptors in the fetal mouse tissues and organs. Anat Embryol 211:109\u2013117","journal-title":"Anat Embryol"},{"key":"3511_CR56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molmet.2016.07.009","volume":"5","author":"PJ Enriori","year":"2016","unstructured":"Enriori PJ et al (2016) alpha-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors. Mol Metab 5:807\u2013822","journal-title":"Mol Metab"},{"key":"3511_CR57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10519-005-9024-9","volume":"36","author":"C Morgan","year":"2006","unstructured":"Morgan C, Cone RD (2006) Melanocortin-5 receptor deficiency in mice blocks a novel pathway influencing pheromone-induced aggression. Behav Genet 36:291\u2013300","journal-title":"Behav Genet"},{"key":"3511_CR58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jdermsci.2011.04.001","volume":"63","author":"M Eisinger","year":"2011","unstructured":"Eisinger M, Li WH, Anthonavage M, Pappas A, Zhang L, Rossetti D, Huang Q, Seiberg M (2011) A melanocortin receptor 1 and 5 antagonist inhibits sebaceous gland differentiation and the production of sebum-specific lipids. J Dermatol Sci 63:23\u201332","journal-title":"J Dermatol Sci"},{"key":"3511_CR59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s13104-015-1539-4","volume":"8","author":"CL Moller","year":"2015","unstructured":"Moller CL, Pedersen SB, Richelsen B, Conde-Frieboes KW, Raun K, Grove KL, Wulff BS (2015) Melanocortin agonists stimulate lipolysis in human adipose tissue explants but not in adipocytes. BMC Res Notes 8:559","journal-title":"BMC Res Notes"},{"key":"3511_CR60","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.metabol.2006.04.001","volume":"55","author":"AL Berg","year":"2006","unstructured":"Berg AL, Rafnsson AT, Johannsson M, Dallongeville J, Arnadottir M (2006) The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins. Metabolism 55:1083\u20131087","journal-title":"Metabolism"},{"key":"3511_CR61","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1242\/jeb.035121","volume":"212","author":"E Sanchez","year":"2009","unstructured":"Sanchez E, Rubio VC, Cerda-Reverter JM (2009) Characterization of the sea bass melanocortin 5 receptor: a putative role in hepatic lipid metabolism. J Exp Biol 212:3901\u20133910","journal-title":"J Exp Biol"},{"key":"3511_CR62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2011.03.010","volume":"341","author":"CL Moller","year":"2011","unstructured":"Moller CL, Raun K, Jacobsen ML, Pedersen TA, Holst B, Conde-Frieboes KW, Wulff BS (2011) Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved. Mol Cell Endocrinol 341:9\u201317","journal-title":"Mol Cell Endocrinol"},{"key":"3511_CR63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.peptides.2005.05.030","volume":"27","author":"L Zhang","year":"2006","unstructured":"Zhang L, Li WH, Anthonavage M, Eisinger M (2006) Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 27:413\u2013420","journal-title":"Peptides"},{"key":"3511_CR64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1152\/physiolgenomics.00011.2004","volume":"18","author":"DH Nguyen","year":"2004","unstructured":"Nguyen DH, Toshida H, Schurr J, Beuerman RW (2004) Microarray analysis of the rat lacrimal gland following the loss of parasympathetic control of secretion. Physiol Genomics 18:108\u2013118","journal-title":"Physiol Genomics"},{"key":"3511_CR65","first-page":"677","volume":"30","author":"M Chang","year":"2019","unstructured":"Chang M, Dworkin LD, Gong R (2019) Melanocortin 5 receptor (MC5R) signaling protects against podocyte injury and proteinuria. J Am Soc Nephrol 30:677","journal-title":"J Am Soc Nephrol"},{"key":"3511_CR66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/07435800009048567","volume":"26","author":"D Pignatelli","year":"2000","unstructured":"Pignatelli D, Maia M, Castro AR, da Conceicao Magalhaes M, Vivier J, Defaye G (2000) Chronic stress effects on the rat adrenal cortex. Endocr Res 26:537\u2013544","journal-title":"Endocr Res"},{"key":"3511_CR67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnins.2015.00213","volume":"9","author":"DS Jackson","year":"2015","unstructured":"Jackson DS, Ramachandrappa S, Clark AJ, Chan LF (2015) Melanocortin receptor accessory proteins in adrenal disease and obesity. Front Neurosci 9:213","journal-title":"Front Neurosci"},{"key":"3511_CR68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejphar.2010.10.100","volume":"660","author":"L Zhang","year":"2011","unstructured":"Zhang L, Li WH, Anthonavage M, Pappas A, Rossetti D, Cavender D, Seiberg M, Eisinger M (2011) Melanocortin-5 receptor and sebogenesis. Eur J Pharmacol 660:202\u2013206","journal-title":"Eur J Pharmacol"},{"key":"3511_CR69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00429-005-0066-9","volume":"211","author":"M Nimura","year":"2006","unstructured":"Nimura M, Udagawa J, Hatta T, Hashimoto R, Otani H (2006) Spatial and temporal patterns of expression of melanocortin type 2 and 5 receptors in the fetal mouse tissues and organs. Anat Embryol (Berl) 211:109\u2013117","journal-title":"Anat Embryol (Berl)"},{"key":"3511_CR70","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.1300182","volume":"191","author":"DJ Lee","year":"2013","unstructured":"Lee DJ, Taylor AW (2013) Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice. J Immunol 191:4103\u20134111","journal-title":"J Immunol"},{"key":"3511_CR71","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1167\/iovs.11-8153","volume":"52","author":"DJ Lee","year":"2011","unstructured":"Lee DJ, Taylor AW (2011) Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen. Invest Ophthalmol Vis Sci 52:8862\u20138867","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-020-03511-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T23:35:12Z","timestamp":1617492912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-020-03511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,4]]},"references-count":71,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03511-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,4]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Gong reports research funding from the Mallincrodt Pharmaceuticals, which is not related to this study. Dr. Gong served as a consultant to the Questcor Pharmaceuticals and the Mallincrodt Pharmaceuticals. All the other authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}